The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law 2025 Breakthroughs in Regenerative Peptides: Spotlight on BPC 157 Mechanisms by Anyniat Karoka Medium of the Federal Food, Drug, and Cosmetic Act (FDCA).* FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida BPC 157 What Athletes Need to Know About Legality, Safety and Efficacy Training & Conditioning